Priya Sachdeva

Stock Analyst at UBS

(1.20)

# 3,418

Out of 5,063 analysts

5

Total ratings

40%

Success rate

-0.59%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$288.47	+16.13%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$14.35	+18.47%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $288.47

Upside: +16.13%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $14.35

Upside: +18.47%